Insight

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Photo from Triantafyllos Stylianopoulos/LinkedIn

Apr 9, 2024, 13:03

Triantafyllos Stylianopoulos: The role of the mast cells in reprogramming the tumor micro-environment

Triantafyllos Stylianopoulos, Associate Professor at the University of Cyprus, Head of Cancer Biophysics Lab, made the following post on LinkedIn:

”Our new article in AACR Journals Clinical Cancer Research for the role of the mast cells in reprogramming the tumor micro-environment! Stabilizing their function with the anti-histamine ketotifen can improve immunotherapy in sarcomas. Early data from our ongoing clinical trial of ketotifen are presented!
This research was supported by the European Research Council (ERC).”

Read further.
Source: Triantafyllos Stylianopoulos/LinkedIn

AACR Journals Clinical Cancer Research cancer Cancer Biophysics Lab clinical trial ERC European Research Council immunotherapy ketotifen OncoDaily Oncology sarcoma Triantafyllos Stylianopoulos tumor micro-environment University of Cyprus

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage